Telum Therapeutics announced today the appointment of Professor Vincent A. Fischetti, that has introduced phage lysins as a new antimicrobial therapy and an alternative to

The concentrations of antibiotic residues found in wastewater and wastewater treatment plants of the WHO Western Pacific region (WPR) and the South-East Asia region (SEAR)

Pamplona, Spain, December 7th 2022.- Telum Therapeutics announced today that Mr. Daniel Couto has been designated to its Board of Directors as an independent director.